These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1701526)

  • 21. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.
    Muller F; Dreux S; Lemeur A; Sault C; Desgrès J; Bernard MA; Giorgetti C; Lemay C; Mirallié S; Beauchet A;
    Prenat Diagn; 2003 Dec; 23(13):1073-6. PubMed ID: 14691995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
    Christiaens GC; Hagenaars AM; Akkerman C; De France HF
    Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
    Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
    J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between maternal serum alpha-fetoprotein and maternal haemoglobin.
    Bartha JL; Omar KM; Soothill PW
    Prenat Diagn; 2004 Aug; 24(8):609-12. PubMed ID: 15305347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
    Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
    Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    Lakartidningen; 1997 Dec; 94(51-52):4898-902. PubMed ID: 9454010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Second trimester Down syndrome serum screening--results from a pilot study].
    Dimitrova V; Chernev T; Kremenski I; Mazneĭkova V; Mikhaĭlova E; Simeonov E; Tincheva R; Toncheva D
    Akush Ginekol (Sofiia); 2002; 41(2):3-12. PubMed ID: 12066548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-stage contingent screening for Down syndrome.
    Wright D; Bradbury I; Cuckle H; Gardosi J; Tonks A; Standing S; Benn P
    Prenat Diagn; 2006 Jun; 26(6):528-34. PubMed ID: 16634118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
    Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
    Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
    Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down syndrome screening in women under 35 with maternal serum hCG.
    Suchy SF; Yeager MT
    Obstet Gynecol; 1990 Jul; 76(1):20-4. PubMed ID: 1694288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unconjugated estriol as maternal serum marker for the detection of Down syndrome pregnancies.
    David M; Merksamer R; Israel N; Dar H
    Fetal Diagn Ther; 1996; 11(2):99-105. PubMed ID: 8838765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers.
    Pergament E; Stein AK; Fiddler M; Cho NH; Kupferminc MJ
    Obstet Gynecol; 1995 Aug; 86(2):255-8. PubMed ID: 7542379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
    Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
    Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.